About: Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 03 December 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) artículu científicu espublizáu n'avientu de 2019 (ast) наукова стаття, опублікована 3 грудня 2019 (uk) scientific article published on 03 December 2019 (en)
publication date	wds:Q91634349-E46FCCAE-3CA4-48D5-A298-7AFC05AD7454
publication date	2019-12-03 00:00:00Z (xsd:dateTime)
cites work	wds:Q91634349-08BABC4A-D4CB-47E3-99F9-E02851716D18 wds:Q91634349-201C731E-E488-4FA7-81C5-C3C09319F739 wds:Q91634349-2D84E524-9DD8-4F2E-AD4B-1BBAA27DC4E2 wds:Q91634349-2F937C03-D1C0-4544-A45D-9770593B386F wds:Q91634349-3704AA84-90B3-4E1C-86EC-2168F614F75A wds:Q91634349-5037B253-785C-4CE3-A1DC-F2E8D9C6F8DD wds:Q91634349-5702C1DF-96C7-4EEF-8CD6-1F2FF567D3EA wds:Q91634349-5EE87DED-15AE-41C6-8ECC-D0A50988949D wds:Q91634349-77B17C1B-182A-49E7-8616-268BBCA19FF5 wds:Q91634349-A0F0E9EF-A4CF-499E-A504-4403E4D66CBC wds:Q91634349-AC6B3A1A-DF13-4FAA-8D3D-7D659C98912B wds:Q91634349-B1E42F5F-A5D1-437D-92BF-DB592ED8367F wds:Q91634349-BADF6B90-B859-4E70-B343-462B76E0288C wds:Q91634349-C520E459-351C-48AC-A167-86A4792415A6 wds:Q91634349-F6417EA8-387C-442F-A2CB-50F92B89649C
cites work	The role of increasing detection in the rising incidence of prostate cancer Screening and prostate-cancer mortality in a randomized European study Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Mortality results from a randomized prostate-cancer screening trial Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Efficient interval estimation for age-adjusted cancer rates Lead time associated with screening for prostate cancer. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement Would prostate cancer detected by screening with prostate-specific antigen develop into clinical cancer if left undiagnosed? A comparison of two population-based studies in Sweden Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States. The Pendulum of Prostate Cancer Screening
author name string	wds:Q91634349-19494788-A099-4AC3-9967-F9B30BEA1C6B wds:Q91634349-2148559F-693A-45CA-8E72-E7AA240DB9A0 wds:Q91634349-4062D630-C5FA-4A2B-8B8F-74331C7FAEC1 wds:Q91634349-5A8512E8-2560-4E54-A3DA-F2D91AC48678 wds:Q91634349-6AC8EAE0-686D-40DE-8209-8C5A385D822C wds:Q91634349-70BE229D-08BE-4AF1-BD75-109A47152357 wds:Q91634349-8BAA7D2C-7BD6-48F1-A588-BCECDB91F29F wds:Q91634349-E7A73CF8-6A5D-44DD-945B-596194073ED7 wds:Q91634349-F06E94AC-2041-45C4-9D93-52D50D75FB46
author name string	Timothy R Rebbeck Felix Y Feng Paul L Nguyen Anthony V D'Amico Vinayak Muralidhar Idalid Franco Shuang G Zhao Janice Chavez Nina N Sanford
rdfs:label	Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 (en) Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 (nl)
skos:prefLabel	Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 (en) Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 (nl)
name	Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 (en) Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 (nl)
author	wds:Q91634349-02CF6700-1B98-42F8-9BA9-711879D5F0DA wds:Q91634349-4211E6C8-AD34-45F1-98DE-26E43A23EBB5 wds:Q91634349-EFE279EE-73BD-451D-9D28-C0B42C5BFDB8
author	Brandon A Mahal Santino S Butler Zoe H Fullerton
title	wds:Q91634349-803D2FFA-DF7C-44F0-8244-5744071FE15E
title	Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012 (en)
page(s)	wds:Q91634349-7C7A6D1F-CB62-4355-8B42-8005BA6CCE65
page(s)	717-724
instance of	wds:Q91634349-570E8955-07A7-49CB-AB6F-C041E3841A66
instance of	scholarly article
PubMed ID	wds:Q91634349-D9418993-52A7-4B4E-9392-0CBEBF8CC5A6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31794057
PubMed ID	31794057
published in	wds:Q91634349-929411E1-D573-44CC-BEBB-E9FC70A2F5AF
published in	Cancer
issue	wds:Q91634349-8F099FD0-0A97-4917-A97F-AD37FB74ACC1
volume	wds:Q91634349-DC40535F-BD13-4A3E-B6F6-01C037A03342
issue	4
volume	126
DOI	wds:Q91634349-8343C6D7-0EF1-45DF-A9BA-CA8804A5CD6B
DOI	http://dx.doi.org/10.1002/CNCR.32604
DOI	10.1002/CNCR.32604
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91634349
is cites work of	Obesity and aggressive prostate cancer The golden rule: Do not do to others what you do not want done to yourself Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China
is cites work of	wds:Q89545553-E68CF297-030A-4332-9070-506FE108C7A3 wds:Q89545684-F7102743-377A-46CD-BC02-5B32C552C29E wds:Q89545577-870C2D5B-2CB8-411B-A13A-F2D6AEC4ABDB wds:Q91634442-06259A22-95BF-4650-B644-A236EAA48CAF wds:Q96136086-14E6CD69-7480-46D0-A8A4-FA33A3FC127D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software